Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference16 articles.
1. Orbach D, Sparber-Sauer M, Laetsch TW, Minard-Colin V, Bielack SS, Casanova M, et al. Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: international consensus and remaining controversies. Eur J Cancer. 2020;137:183–92.
2. Orbach D, Brennan B, De Paoli A, Gallego S, Mudry P, Francotte N, et al. Conservative strategy in infantile fibrosarcoma is possible: the European paediatric Soft tissue sarcoma study group experience. Eur J Cancer. 2016;57:1–9.
3. Forsythe A, Zhang W, Phillip Strauss U, Fellous M, Korei M, Keating K. A systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumors. Ther Adv Med Oncol. 2020;12:1758835920975613.
4. Looney A-M, Nawaz K, Webster RM. Tumour-agnostic therapies. Nat Rev Drug Discov. 2020;19:383–4.
5. Van Tilburg C, Albert C, Bielack S, Dubois S, Federman N, Geoerger B, et al. SIOP ABSTRACTS - O0112 / #485 Efficacy and safety of Larotrectinib in pediatric patients with non-central nervous system (CNS) tropomyosin receptor kinase (TRK) Fusion-positive cancer: an expanded dataset. Pediatr Blood Cancer. 2021;68:S54–S54.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献